company background image
HEAL

Medikaloka Hermina IDX:HEAL Stock Report

Last Price

Rp1.44k

Market Cap

Rp20.9t

7D

4.7%

1Y

55.0%

Updated

26 May, 2022

Data

Company Financials +
HEAL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends0/6

HEAL Stock Overview

PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia.

Rewards

Earnings have grown 56.2% per year over the past 5 years

Risk Analysis

No risks detected for HEAL from our risk checks.

Medikaloka Hermina Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medikaloka Hermina
Historical stock prices
Current Share PriceRp1,435.00
52 Week HighRp1,480.00
52 Week LowRp872.00
Beta0.65
1 Month Change3.24%
3 Month Change34.74%
1 Year Change54.97%
3 Year Change105.59%
5 Year Changen/a
Change since IPO126.34%

Recent News & Updates

Shareholder Returns

HEALID HealthcareID Market
7D4.7%5.4%0.5%
1Y55.0%22.0%16.4%

Return vs Industry: HEAL exceeded the ID Healthcare industry which returned 22% over the past year.

Return vs Market: HEAL exceeded the ID Market which returned 16.4% over the past year.

Price Volatility

Is HEAL's price volatile compared to industry and market?
HEAL volatility
HEAL Average Weekly Movement4.4%
Healthcare Industry Average Movement5.8%
Market Average Movement6.2%
10% most volatile stocks in ID Market12.0%
10% least volatile stocks in ID Market2.9%

Stable Share Price: HEAL is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: HEAL's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198512,752H. Hasmorohttps://www.herminahospitals.com

PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. As of December 31, 2021, the company operated 43 hospitals with 5,877 beds. It is also involved in the investment and education service businesses.

Medikaloka Hermina Fundamentals Summary

How do Medikaloka Hermina's earnings and revenue compare to its market cap?
HEAL fundamental statistics
Market CapRp20.94t
Earnings (TTM)Rp1.00t
Revenue (TTM)Rp5.82t

20.9x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HEAL income statement (TTM)
RevenueRp5.82t
Cost of RevenueRp3.11t
Gross ProfitRp2.71t
Other ExpensesRp1.71t
EarningsRp1.00t

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)68.75
Gross Margin46.65%
Net Profit Margin17.24%
Debt/Equity Ratio37.9%

How did HEAL perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

7%

Payout Ratio

Valuation

Is Medikaloka Hermina undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


20.87x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: HEAL (IDR1435) is trading above our estimate of fair value (IDR827.52)

Significantly Below Fair Value: HEAL is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: HEAL is poor value based on its Price-To-Earnings Ratio (20.9x) compared to the ID Healthcare industry average (20x).

PE vs Market: HEAL is poor value based on its Price-To-Earnings Ratio (20.9x) compared to the ID market (18.4x).


Price to Earnings Growth Ratio

PEG Ratio: HEAL is poor value based on its PEG Ratio (13.8x)


Price to Book Ratio

PB vs Industry: HEAL is overvalued based on its Price-To-Book Ratio (6.4x) compared to the ID Healthcare industry average (2x).


Future Growth

How is Medikaloka Hermina forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


1.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HEAL's forecast earnings growth (1.5% per year) is below the savings rate (7%).

Earnings vs Market: HEAL's earnings (1.5% per year) are forecast to grow slower than the ID market (11.2% per year).

High Growth Earnings: HEAL's earnings are forecast to grow, but not significantly.

Revenue vs Market: HEAL's revenue (8.5% per year) is forecast to grow slower than the ID market (11.4% per year).

High Growth Revenue: HEAL's revenue (8.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HEAL's Return on Equity is forecast to be high in 3 years time (21.3%)


Past Performance

How has Medikaloka Hermina performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


56.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: HEAL has high quality earnings.

Growing Profit Margin: HEAL's current net profit margins (17.2%) are higher than last year (10.7%).


Past Earnings Growth Analysis

Earnings Trend: HEAL's earnings have grown significantly by 56.2% per year over the past 5 years.

Accelerating Growth: HEAL's earnings growth over the past year (112%) exceeds its 5-year average (56.2% per year).

Earnings vs Industry: HEAL earnings growth over the past year (112%) underperformed the Healthcare industry 121.6%.


Return on Equity

High ROE: HEAL's Return on Equity (29.6%) is considered high.


Financial Health

How is Medikaloka Hermina's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: HEAL's short term assets (IDR2,465.7B) exceed its short term liabilities (IDR1,617.1B).

Long Term Liabilities: HEAL's short term assets (IDR2,465.7B) exceed its long term liabilities (IDR1,582.8B).


Debt to Equity History and Analysis

Debt Level: HEAL's net debt to equity ratio (8.6%) is considered satisfactory.

Reducing Debt: HEAL's debt to equity ratio has reduced from 48.4% to 37.9% over the past 5 years.

Debt Coverage: HEAL's debt is well covered by operating cash flow (111.6%).

Interest Coverage: HEAL's interest payments on its debt are well covered by EBIT (14.8x coverage).


Balance Sheet


Dividend

What is Medikaloka Hermina current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.35%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: HEAL's dividend (0.35%) isn’t notable compared to the bottom 25% of dividend payers in the ID market (1.14%).

High Dividend: HEAL's dividend (0.35%) is low compared to the top 25% of dividend payers in the ID market (4.16%).


Stability and Growth of Payments

Stable Dividend: HEAL is not paying a notable dividend for the ID market, therefore no need to check if payments are stable.

Growing Dividend: HEAL is not paying a notable dividend for the ID market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: HEAL is not paying a notable dividend for the ID market.


Cash Payout to Shareholders

Cash Flow Coverage: HEAL is not paying a notable dividend for the ID market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

H. Hasmoro (77 yo)

31.33yrs

Tenure

Dr. H. Hasmoro, Sp An, KIC, MHA, MM, has been President Director of PT Medikaloka Hermina Tbk since 1991. Previously, Dr. Hasmoro served as Member of Presidential Specialist Team from 1987 to 2000.He join...


Leadership Team

Experienced Management: HEAL's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: HEAL's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Medikaloka Hermina Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Medikaloka Hermina Tbk
  • Ticker: HEAL
  • Exchange: IDX
  • Founded: 1985
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: Rp20.938t
  • Shares outstanding: 14.59b
  • Website: https://www.herminahospitals.com

Number of Employees


Location

  • PT Medikaloka Hermina Tbk
  • Hermina Tower
  • Jalan Selangit B-10 Kavling 4
  • Jakarta
  • Jakarta Raya
  • 10610
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/26 00:00
End of Day Share Price2022/05/25 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.